No Prescription |
 |
 | ||
|
Januvia Generic Sitagliptin Phosphate |
|
| ||
No Prescription » Prescription Drugs 9 » Januvia Generic Sitagliptin Phosphate Sitagliptin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes (non-insulin-dependent diabetes). Controlling blood sugar helps to prevent heart disease strokes kidney disease blindness circulation problems and sexual function problems. Sitagliptin may be used alone or with other diabetes medications taken by mouth (e.g. metformin rosiglitazone pioglitazone).This drug works by increasing levels of natural hormones called incretins. Incretins help to control blood sugar and increase insulin release especially after a meal. They also decrease the amount of sugar your liver makes.How to use Januvia OralRead the Patient Information Leaflet provided by your pharmacist before you start using sitagliptin and each time you get a refill. If you have any questions consult your doctor or pharmacist.Take this medication by mouth with or without food usually once daily or as directed by your doctor.The dosage is based on your medical condition and response to treatment.Use this medication regularly to get the most benefit from it. To help you remember take it at the same time each day.Check your blood sugar regularly as directed by your doctor and tell your doctor the results. Tell your doctor if your blood sugar is too high or low.What conditions does this medication treat?Januvia Oral is used to treat the following:Type 2 Diabetes Mellitus Buy Januvia Generic Sitagliptin Phosphate and other Prescription Drugs 9 products online at Medstore. Buy Online at Medstore - Click Here!
About Januvia Generic Sitagliptin Phosphate: Product Type: Prescription Drugs 9 Januvia ( Generic Sitagliptin Phosphate ) Januvia (Generic Sitagliptin Phosphate) Generic Sitagliptin Phosphate 100mg 14 Tablets 100mg 4 x 14 Tablets 100mg 2 x 14 Tablets 25mg 4 x 7 Tablets 25mg 2 x 7 Tablets 25mg 7 Tablets 50mg 2 x 7 Tablets 50mg 4 x 7 Tablets 50mg 7 Tablets Generic Sitagliptin Phosphate Januvia
View more Prescription Drugs 9 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
